Monash University Discovery Uncovers Clue to Disarm Gonorrhea Superbug

Article

Every year, more than 100 million people worldwide develop the sexually transmitted disease gonorrhea, with health consequences such as infertility, transmission of the disease to newborn babies, and increased risk of HIV infections. There has been a 63 percent rise in gonorrhea in Australia over the past five years.

Gonorrhoea is caused by bacteria which can rapidly develop resistance to all known antibiotics -- commonly called 'superbugs.' Gonorrhea superbugs have now been detected in every Australian state and territory and are increasingly difficult to treat in the clinic.

Monash University researchers have discovered a way the gonorrhoea bacteria cleverly evade the immune system - opening up the way for therapies that prevent this process, allowing the body's natural defences to kill the bug.

Published today in PLOS Pathogens, Dr. Thomas Naderer and Dr. Pankaj Deo and their team from the Monash Biomedicine Discovery Institute, have discovered how the gonorrhea-causing superbug (which is very small) creates even smaller packages of bacterial membrane blebs, termed vesicles, which attack immune cells.

Using cutting-edge super-resolution microscopy, which is able to see, and film, the most minute of events - the researchers found that these membrane vesicles interacted with the cells in the human immune system called 'macrophages', triggering these to die in an orchestrated suicide process. Macrophages are the cells within the immune system that ordinarily kill foreign invaders like bacteria and viruses, so without them the gonorrhoea bacteria can flourish.

Naderer said that this new understanding of how the gonorrhea bacteria interact and cause the death of immune system cells "may lead to strategies to combat gonorrhea infection and its symptoms".

The research may also provide information as to how other bacteria evade the immune system and be unaffected by antibiotics. The 2016 Review on Antimicrobial Resistance Final Report and Recommendations states that antibiotic resistant infection will kill an extra 10 million people a year worldwide - more than currently die from cancer - by 2050 unless action is taken.

Source: Monash Biomedicine Discovery Institute

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content